In this week’s video, Dr. Brian Durie discusses Selinexor, a novel, orally administered drug that is currently ongoing clinical trials.
Bottom Line:
Selinexor is a promising new type of drug that can make a difference for myeloma patients.
Advertisement
Visit our website at: http://www.myeloma.org
Find us online:
Facebook: http://facebook.com/myeloma
Google+: http://gplus.to/imfmyeloma
IMF on twitter: @IMFMyeloma (http://twitter.com/imfmyeloma)
Dr. Durie on twitter: @BrianDurieMD (http://twitter.com/brianduriemd)